The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

Clicks: 469
ID: 117598
2000
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Antibiotic treatment of children with E. coli O157:H7 infection increases the risk of the hemolytic-uremic syndrome.
Reference Key
cs2000thethe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Wong CS;Jelacic S;Habeeb RL;Watkins SL;Tarr PI;;
Journal The New England journal of medicine
Year 2000
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10874060
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine logistic models research support u.s. gov't female male Child Infant Prospective Studies P.H.S. preschool Diarrhea / complications anti-bacterial agents / therapeutic use diarrhea / drug therapy* escherichia coli infections / complications diarrhea / microbiology feces / microbiology risk trimethoprim sulfamethoxazole drug combination / adverse effects anti-bacterial agents / adverse effects* escherichia coli infections / drug therapy* escherichia coli o157* pmid:10874060 pmc3659814 doi:10.1056/nejm200006293422601 c s wong s jelacic p i tarr cephalosporins / adverse effects escherichia coli infections / microbiology hemolytic-uremic syndrome / etiology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.